The use of salicylates (popularly known as aspirin or ASA) is well established for the secondary prevention of cardiovascular disease. However, there are reportedly a numer of patients who suffered repeat cardiovascular events despite being given aspirin “prophylaxis”, and uncertainty prevails on whether or not this is due to an inherent inability of aspirin to sufficiently modify platelet activity or are there other mechanisms involved. Coined as “aspirinresistance”, the condition warrants attention as an ineffective prophylaxis may lead to unexpected morbidity and subsequent disappointmen
Dual antiplatelet therapy has been proven effective to reduce recurrent cardiovascular eventin patie...
Aspirin (acetylsalicylic acid) is a powerful antiplatelet agent used in prevention of atherothrombot...
Background: Aspirin use is known to reduce the recurrence of stroke. However, the clinical response ...
The use of salicylates (popularly known as aspirin or ASA) is well established for the secondary pre...
Aspirin is well recognized as an effective antiplatelet drug for secondary prevention in subjects at...
Aspirin is the most commonly used antiplatelet drug in the secondary prevention of cardiovascular ev...
Aspirin irreversibly acetylates serine 529 of cyclooxygenase (COX)-1, resulting in inhibition of thr...
The increased risk of vascular disease in a subgroup of patients judged to be “resistant” to aspirin...
Background: Aspirin is one of the most widely consumed drugs in this world. The first report of a po...
Platelets play a crucial role in the pathogenesis of atherosclerosis, thrombosis, and stroke. Aspiri...
Acute coronary syndromes and other manifestations of atherothrombotic disease are primarily caused b...
Background: Aspirin is first line drug of choice to prevent ischemic stroke. However, some cases a...
AbstractObjectivesThis study was designed to determine if aspirin resistance is associated with clin...
Introduction: The antiplatelet drug aspirin is considered as a cornerstone in medical treatment of p...
Aspirin is integral in the primary and secondary prevention of coronary artery disease and acute cor...
Dual antiplatelet therapy has been proven effective to reduce recurrent cardiovascular eventin patie...
Aspirin (acetylsalicylic acid) is a powerful antiplatelet agent used in prevention of atherothrombot...
Background: Aspirin use is known to reduce the recurrence of stroke. However, the clinical response ...
The use of salicylates (popularly known as aspirin or ASA) is well established for the secondary pre...
Aspirin is well recognized as an effective antiplatelet drug for secondary prevention in subjects at...
Aspirin is the most commonly used antiplatelet drug in the secondary prevention of cardiovascular ev...
Aspirin irreversibly acetylates serine 529 of cyclooxygenase (COX)-1, resulting in inhibition of thr...
The increased risk of vascular disease in a subgroup of patients judged to be “resistant” to aspirin...
Background: Aspirin is one of the most widely consumed drugs in this world. The first report of a po...
Platelets play a crucial role in the pathogenesis of atherosclerosis, thrombosis, and stroke. Aspiri...
Acute coronary syndromes and other manifestations of atherothrombotic disease are primarily caused b...
Background: Aspirin is first line drug of choice to prevent ischemic stroke. However, some cases a...
AbstractObjectivesThis study was designed to determine if aspirin resistance is associated with clin...
Introduction: The antiplatelet drug aspirin is considered as a cornerstone in medical treatment of p...
Aspirin is integral in the primary and secondary prevention of coronary artery disease and acute cor...
Dual antiplatelet therapy has been proven effective to reduce recurrent cardiovascular eventin patie...
Aspirin (acetylsalicylic acid) is a powerful antiplatelet agent used in prevention of atherothrombot...
Background: Aspirin use is known to reduce the recurrence of stroke. However, the clinical response ...